ZNF254
gene geneOn this page
Also known as HD-ZNF1BMZF-5
Summary
ZNF254 (zinc finger protein 254, HGNC:13047) is a protein-coding gene on chromosome 19p13, encoding Zinc finger protein 254 (O75437). May be involved in transcriptional regulation.
Zinc finger proteins have been shown to interact with nucleic acids and to have diverse functions. The zinc finger domain is a conserved amino acid sequence motif containing 2 specifically positioned cysteines and 2 histidines that are involved in coordinating zinc. Kruppel-related proteins form 1 family of zinc finger proteins. See ZFP93 (MIM 604749) for additional information on zinc finger proteins.
Source: NCBI Gene 9534 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 154 total
- MANE Select transcript:
NM_203282
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13047 |
| Approved symbol | ZNF254 |
| Name | zinc finger protein 254 |
| Location | 19p13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HD-ZNF1, BMZF-5 |
| Ensembl gene | ENSG00000213096 |
| Ensembl biotype | protein_coding |
| OMIM | 604768 |
| Entrez | 9534 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 5 protein_coding, 2 nonsense_mediated_decay, 1 retained_intron
ENST00000339642, ENST00000357002, ENST00000593783, ENST00000594886, ENST00000595187, ENST00000611359, ENST00000613065, ENST00000616028
RefSeq mRNA: 8 — MANE Select: NM_203282
NM_001278661, NM_001278662, NM_001278663, NM_001278664, NM_001278665, NM_001278677, NM_001278678, NM_203282
CCDS: CCDS32983, CCDS62622, CCDS62623, CCDS74323, CCDS74324
Canonical transcript exons
ENST00000357002 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003158150 | 24126254 | 24129968 |
| ENSE00003174182 | 24087187 | 24087337 |
| ENSE00003469299 | 24105940 | 24106066 |
| ENSE00003521622 | 24106548 | 24106643 |
Expression profiles
Bgee: expression breadth ubiquitous, 241 present calls, max score 93.79.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 34.4915 / max 569.3175, expressed in 1800 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 174932 | 23.5080 | 1786 |
| 174938 | 7.9046 | 1571 |
| 174936 | 1.6879 | 904 |
| 174931 | 0.5991 | 330 |
| 174937 | 0.3250 | 160 |
| 174939 | 0.2942 | 157 |
| 174940 | 0.1727 | 72 |
Top tissues by expression
280 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 93.79 | gold quality |
| ganglionic eminence | UBERON:0004023 | 90.38 | gold quality |
| ventricular zone | UBERON:0003053 | 89.12 | gold quality |
| calcaneal tendon | UBERON:0003701 | 88.75 | gold quality |
| tendon | UBERON:0000043 | 88.34 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 88.27 | silver quality |
| cortical plate | UBERON:0005343 | 85.58 | gold quality |
| adrenal tissue | UBERON:0018303 | 85.41 | gold quality |
| medial globus pallidus | UBERON:0002477 | 84.94 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 83.44 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.79 | gold quality |
| globus pallidus | UBERON:0001875 | 82.52 | gold quality |
| sperm | CL:0000019 | 82.50 | silver quality |
| corpus callosum | UBERON:0002336 | 82.45 | gold quality |
| amniotic fluid | UBERON:0000173 | 82.00 | silver quality |
| oocyte | CL:0000023 | 81.87 | silver quality |
| islet of Langerhans | UBERON:0000006 | 81.55 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 81.42 | silver quality |
| colonic epithelium | UBERON:0000397 | 81.06 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 80.82 | gold quality |
| thyroid gland | UBERON:0002046 | 80.81 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 80.15 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 80.13 | gold quality |
| rectum | UBERON:0001052 | 80.05 | gold quality |
| left ovary | UBERON:0002119 | 79.88 | gold quality |
| male germ cell | CL:0000015 | 79.78 | silver quality |
| tonsil | UBERON:0002372 | 79.55 | gold quality |
| right ovary | UBERON:0002118 | 79.53 | gold quality |
| endometrium | UBERON:0001295 | 79.39 | gold quality |
| endocervix | UBERON:0000458 | 78.99 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.48 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): STAT1
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 254 — O75437 (reviewed: O75437)
Alternative names: Bone marrow zinc finger 5, Hematopoietic cell-derived zinc finger protein 1, Zinc finger protein 539, Zinc finger protein 91-like
All UniProt accessions (7): A0A087WZJ7, A0A087X0A2, O75437, F5H2M4, M0QZY2, M0R2X5, Q7Z2R1
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| O75437-1 | 1 | yes |
| O75437-2 | 2 |
RefSeq proteins (8): NP_001265590, NP_001265591, NP_001265592, NP_001265593, NP_001265594, NP_001265606, NP_001265607, NP_975011* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050589 | Ikaros_C2H2-ZF | Family |
Pfam: PF00096, PF01352, PF13465
UniProt features (25 total): zinc finger region 15, sequence variant 5, sequence conflict 2, chain 1, domain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O75437-F1 | 69.67 | 0.12 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 83 (showing top):
MODULE_229, MILI_PSEUDOPODIA_HAPTOTAXIS_UP, SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4, BLALOCK_ALZHEIMERS_DISEASE_UP, chr19p12, MODULE_123, DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP, MODULE_318, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, YAGI_AML_WITH_T_8_21_TRANSLOCATION, TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, PASINI_SUZ12_TARGETS_UP, PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS
GO Biological Process (3): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of transcription by RNA polymerase II | 2 |
| transcription by RNA polymerase II | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| negative regulation of DNA-templated transcription | 1 |
| regulation of DNA-templated transcription | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
492 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF254 | ICA1 | P78506 | 438 |
| ZNF254 | FAM124B | Q9H5Z6 | 418 |
| ZNF254 | RPP38 | P78345 | 401 |
| ZNF254 | PKP2 | Q99959 | 398 |
| ZNF254 | CD34 | P28906 | 388 |
| ZNF254 | FAM219B | Q5XKK7 | 380 |
| ZNF254 | ASAP2 | O43150 | 374 |
| ZNF254 | CCNI2 | Q6ZMN8 | 374 |
| ZNF254 | MORN3 | Q6PF18 | 362 |
| ZNF254 | CCDC148 | Q8NFR7 | 348 |
| ZNF254 | LRP5L | A4QPB2 | 333 |
| ZNF254 | MZT2A | Q6P582 | 321 |
| ZNF254 | FBXO41 | Q8TF61 | 308 |
| ZNF254 | SLC6A16 | Q9GZN6 | 307 |
| ZNF254 | COMMD2 | Q86X83 | 307 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRIM44 | ODAD3 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF254 | ADRB2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ECE1 | ZNF254 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF467 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| LTBP2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF254 | TRIM24 | psi-mi:“MI:0914”(association) | 0.350 |
| TRIM44 | ZNF254 | psi-mi:“MI:0914”(association) | 0.350 |
| NDEL1 | ZNF254 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (15): ZNF254 (Affinity Capture-MS), TRIM28 (Affinity Capture-MS), ZNF479 (Affinity Capture-MS), CYP24A1 (Affinity Capture-MS), TRIM24 (Affinity Capture-MS), ZNF254 (Affinity Capture-RNA), ZNF254 (Two-hybrid), TRIM28 (Affinity Capture-MS), ZNF254 (Affinity Capture-MS), CYP24A1 (Affinity Capture-MS), ZNF254 (Affinity Capture-MS), ZNF479 (Affinity Capture-MS), ZNF254 (Affinity Capture-MS), TRIM24 (Affinity Capture-MS), ZNF254 (Affinity Capture-RNA)
ESM2 similar proteins: A2VDQ7, A6NK75, A6NN14, A6NNF4, A8MQ14, A8MTY0, A8MXY4, B7Z6K7, E9QAG8, O43345, O75290, O75373, O75437, P0CJ79, P10751, P17017, P17019, P17035, P17038, P18749, P35789, P51522, Q03923, Q03938, Q05481, Q14585, Q3SYV7, Q4V348, Q5R5U3, Q5R8X1, Q5R9F0, Q5SXM1, Q6P5C7, Q6ZN08, Q6ZN57, Q6ZR52, Q86V71, Q86XN6, Q8IYB9, Q8N7Q3
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
154 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 138 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
706 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:24105936:CCAG:C | acceptor_loss | 1.0000 |
| 19:24105937:CAG:C | acceptor_loss | 1.0000 |
| 19:24105938:A:AG | acceptor_gain | 1.0000 |
| 19:24105938:A:T | acceptor_loss | 1.0000 |
| 19:24105938:AG:A | acceptor_gain | 1.0000 |
| 19:24105938:AGG:A | acceptor_gain | 1.0000 |
| 19:24105939:G:GG | acceptor_gain | 1.0000 |
| 19:24105939:G:T | acceptor_loss | 1.0000 |
| 19:24105939:GG:G | acceptor_gain | 1.0000 |
| 19:24105939:GGG:G | acceptor_gain | 1.0000 |
| 19:24105939:GGGA:G | acceptor_gain | 1.0000 |
| 19:24105939:GGGAC:G | acceptor_gain | 1.0000 |
| 19:24106063:CTGGG:C | donor_loss | 1.0000 |
| 19:24106064:TGGGT:T | donor_loss | 1.0000 |
| 19:24106066:GGT:G | donor_loss | 1.0000 |
| 19:24106067:G:GG | donor_gain | 1.0000 |
| 19:24106068:T:A | donor_loss | 1.0000 |
| 19:24126252:AGGT:A | acceptor_loss | 1.0000 |
| 19:24126253:GGTAT:G | acceptor_gain | 1.0000 |
| 19:24087303:C:G | donor_gain | 0.9900 |
| 19:24106065:GG:G | donor_gain | 0.9900 |
| 19:24106066:GG:G | donor_gain | 0.9900 |
| 19:24106069:G:GG | donor_loss | 0.9900 |
| 19:24106072:GA:G | donor_gain | 0.9900 |
| 19:24106545:CAGGT:C | acceptor_loss | 0.9900 |
| 19:24106547:GGT:G | acceptor_gain | 0.9900 |
| 19:24106640:CCAG:C | donor_loss | 0.9900 |
| 19:24106643:GGTA:G | donor_loss | 0.9900 |
| 19:24106645:T:A | donor_loss | 0.9900 |
| 19:24126252:A:AG | acceptor_gain | 0.9900 |
AlphaMissense
4368 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:24127495:T:C | F499L | 0.985 |
| 19:24127497:T:A | F499L | 0.985 |
| 19:24127497:T:G | F499L | 0.985 |
| 19:24127411:T:C | F471L | 0.982 |
| 19:24127413:T:A | F471L | 0.982 |
| 19:24127413:T:G | F471L | 0.982 |
| 19:24127579:T:C | F527L | 0.974 |
| 19:24127581:T:A | F527L | 0.974 |
| 19:24127581:T:G | F527L | 0.974 |
| 19:24127075:T:C | F359L | 0.973 |
| 19:24127077:T:A | F359L | 0.973 |
| 19:24127077:T:G | F359L | 0.973 |
| 19:24127327:T:C | F443L | 0.972 |
| 19:24127329:T:A | F443L | 0.972 |
| 19:24127329:T:G | F443L | 0.972 |
| 19:24105973:T:C | F22L | 0.968 |
| 19:24105975:C:A | F22L | 0.968 |
| 19:24105975:C:G | F22L | 0.968 |
| 19:24127747:T:C | F583L | 0.966 |
| 19:24127749:T:A | F583L | 0.966 |
| 19:24127749:T:G | F583L | 0.966 |
| 19:24127663:T:C | F555L | 0.964 |
| 19:24127665:T:A | F555L | 0.964 |
| 19:24127665:T:G | F555L | 0.964 |
| 19:24127243:T:C | F415L | 0.961 |
| 19:24127245:T:A | F415L | 0.961 |
| 19:24127245:T:G | F415L | 0.961 |
| 19:24126907:T:C | F303L | 0.959 |
| 19:24126909:T:A | F303L | 0.959 |
| 19:24126909:T:G | F303L | 0.959 |
dbSNP variants (sampled 300 via entrez): RS1000043260 (19:24032527 A>C), RS1000044442 (19:24129696 T>C), RS1000068731 (19:24117026 A>C), RS1000077972 (19:24053839 A>G), RS1000097765 (19:24129725 T>C), RS1000156144 (19:24104146 C>T), RS1000191725 (19:24053632 C>G,T), RS1000196943 (19:24094087 C>T), RS1000207484 (19:24062896 G>A), RS1000215722 (19:24049655 T>C), RS1000275259 (19:24053868 T>G), RS1000280808 (19:24059314 C>A), RS1000281781 (19:24065894 C>T), RS1000284233 (19:24083020 G>A), RS1000299216 (19:24071656 T>A,C)
Disease associations
OMIM: gene MIM:604768 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001692_12 | Response to taxane treatment (docetaxel) | 3.000000e-06 |
| GCST001694_11 | Response to taxane treatment (paclitaxel) | 6.000000e-06 |
| GCST003437_3 | Discordance in emotional problems in monozygotic twins | 6.000000e-06 |
| GCST009863_26 | Insulin-related traits (multivariate analysis) | 2.000000e-08 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007803 | emotional symptom measurement |
| EFO:0004467 | insulin measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
35 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression, affects expression, affects cotreatment | 7 |
| sodium arsenite | decreases expression, increases abundance, increases expression | 3 |
| trichostatin A | affects cotreatment, decreases expression | 2 |
| perfluorooctane sulfonic acid | decreases expression | 2 |
| Arsenic | increases expression, affects methylation, increases abundance | 2 |
| Benzo(a)pyrene | affects methylation, decreases expression, decreases methylation | 2 |
| aristolochic acid I | decreases expression | 1 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| butyraldehyde | decreases expression | 1 |
| entinostat | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | decreases expression, decreases reaction | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| jinfukang | decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Vorinostat | decreases expression | 1 |
| Vehicle Emissions | decreases expression, decreases reaction | 1 |
| Cisplatin | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Gallic Acid | decreases expression | 1 |
| Lead | affects expression | 1 |
| Mercury | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Nickel | decreases expression | 1 |
| Thiram | increases expression | 1 |
| Urethane | increases expression | 1 |
| Vanadates | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.